Cargando…
Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
The retention and cellular internalization of drug delivery systems and theranostics for cancer therapy can be improved by targeting molecules. Since an increased uptake of riboflavin was reported for various cancers, riboflavin and its derivatives may be promising binding moieties to trigger intern...
Autores principales: | Bartmann, Lisa, Schumacher, David, von Stillfried, Saskia, Sternkopf, Marieke, Alampour-Rajabi, Setareh, van Zandvoort, Marc A. M. J., Kiessling, Fabian, Wu, Zhuojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372557/ https://www.ncbi.nlm.nih.gov/pubmed/30787877 http://dx.doi.org/10.3389/fphar.2019.00079 |
Ejemplares similares
-
Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics
por: Bartmann, Lisa, et al.
Publicado: (2020) -
Riboflavin-Targeted Drug Delivery
por: Darguzyte, Milita, et al.
Publicado: (2020) -
Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers
por: Beztsinna, Nataliia, et al.
Publicado: (2017) -
Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery
por: Mishra, Shivani, et al.
Publicado: (2023) -
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery
por: Paefgen, Vera, et al.
Publicado: (2015)